We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

113 hedge funds and large institutions have $323M invested in Emergent Biosolutions in 2013 Q2 according to their latest regulatory filings, with 113 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

64.42% more ownership

Funds ownership: 0% → 64.42% (+64%)

Holders
113
Holders Change
+113
Holders Change %
–
% of All Funds
3.69%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
113
Increased
–
Reduced
–
Closed
–
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CMBA
101
C.M. Bidwell & Associates
Hawaii
$79.7K +$80.1K +5,530 New
OA
102
OFI Advisors
Pennsylvania
$73K +$73K +5,040 New
MSA
103
Mason Street Advisors
Wisconsin
$51K +$51.4K +3,553 New
PI
104
PineBridge Investments
New York
$41K +$41.7K +2,878 New
Public Employees Retirement Association of Colorado
105
Public Employees Retirement Association of Colorado
Colorado
$32K +$32.1K +2,215 New
Teacher Retirement System of Texas
106
Teacher Retirement System of Texas
Texas
$28K +$28.3K +1,953 New
ILIM
107
Irish Life Investment Managers
Ireland
$21.7K +$21.8K +1,505 New
BlackRock
108
BlackRock
New York
$13K +$12.8K +883 New
Loomis, Sayles & Company
109
Loomis, Sayles & Company
Massachusetts
$12.6K +$12.7M +875,229 New
MWP
110
MYCIO Wealth Partners
Pennsylvania
$7K +$7.24K +500 New
TWI
111
Thomas White International
Illinois
$6K +$6.01K +415 New
TRCT
112
Tower Research Capital (TRC)
New York
$4K +$4.34K +300 New
HRIA
113
Haberer Registered Investment Advisor
Ohio
– +$72 +5 New
1 2 3 4
5

EBS Hedge Fund Activity: Q2 2013 in Review

113 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q2 2013, worth a combined $323M.

Buyers outnumbered sellers: 113 funds opened new EBS positions and 0 closed out — a net gain of 113 holders — while 0 added to existing stakes and 0 trimmed.

  • 113 institutional investors held Emergent Biosolutions (EBS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $323M of Emergent Biosolutions stock for Q2 2013.
  • 113 funds opened new Emergent Biosolutions positions in Q2 2013 and 0 closed out, a net change of +113 holders.

Based on aggregated 13F filings for Q2 2013.